Co-Diagnostics Seeks Shareholder Nod for 2M-Share Equity Plan Boost and Quorum Cut
CODX has more than doubled off its 52-week low of $1.26.
Summary
Co-Diagnostics' preliminary proxy seeks approval to expand its equity plan by 2 million shares—a potential 37.9% dilution—and to lower the quorum threshold for shareholder meetings to one-third.
Key Events · Corporate Governance and Compliance · CODX
-
Equity Plan Increase Requested
A proposal to add 2,000,000 shares to the 2025 Equity Incentive Plan would lift the reserve from 223,333 to 2,223,333 shares, creating potential dilution of up to 37.9% of the 5.3 million shares outstanding.
-
Quorum Reduction Proposed
An amendment to the Articles of Incorporation would lower the quorum requirement for shareholder meetings from a majority to one-third, potentially making it easier to pass future proposals with less shareholder participation.
-
Director Elections and Auditor Ratification
Shareholders will vote on the election of five directors—all incumbents—and the ratification of Tanner LLC as the independent auditor for FY2026.
-
Say-on-Pay Advisory Vote
An advisory vote on executive compensation is included, with the board recommending approval.
Analysis · CODX · Industrial Applications And Services
Shareholders are being asked to greenlight a 2-million-share expansion of the 2025 Equity Incentive Plan, which would swell the reserve nearly tenfold to 2.2 million shares. For a micro-cap already burning cash and operating under a going-concern warning, the potential dilution of up to 37.9% of the current 5.3 million shares outstanding is a significant overhang. Management contends the shares are essential to attract and retain talent while preserving cash, but the sheer size of the request relative to the existing share count stands out. In a separate governance move, the board wants to lower the quorum requirement for shareholder meetings from a majority to one-third—a change that could ease the passage of future proposals with less shareholder participation. The proxy also carries routine items: the election of five directors, ratification of Tanner LLC as auditor, and an advisory say-on-pay vote.
At the time of this filing, CODX was trading at $2.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.7M. The 52-week trading range was $1.26 to $46.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.